Mitoxantrone hydrochloride liposome(The First Affiliated Hospital Of Xiamen University)

N/A

Report date: 2025/10/29 11:43:29

Base Information

Drug NameMitoxantrone hydrochloride liposome(The First Affiliated Hospital Of Xiamen University)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionHepatitis C virus serine protease, NS3/NS4A inhibitorsProto-oncogene serine/threonine-protein kinase Pim-1 inhibitorsTopoisomerase II inhibitors
TargetsTopoisomerase IIProto-oncogene serine/threonine-protein kinase Pim-1Hepatitis C virus serine protease, NS3/NS4A
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesThe First Affiliated Hospital Of Xiamen University
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Xiamen University
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A